Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study (Q31118126)

16 August 2017

Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study (English)

1 reference

chronic renal insufficiency

16 August 2017

1 reference

3

Svend Strandgaard

1 reference

16 August 2017

0 references

Lene Boesby

1

1 reference

16 August 2017

Thomas Elung-Jensen

series ordinal

2

1 reference

16 August 2017

Anne-Lise Kamper

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

21 May 2013

1 reference

16 August 2017

1 reference

16 August 2017

8

1 reference

16 August 2017

5

1 reference

16 August 2017

e64549

1 reference

Creative Commons Attribution 4.0 International

16 August 2017

start time

21 May 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease--a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Moderate antiproteinuric effect of add-on aldosterone blockade with eplerenone in non-diabetic chronic kidney disease. A randomized cross-over study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Aldosterone: effects on the kidney and cardiovascular system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

A new equation to estimate glomerular filtration rate

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Aldosterone and vascular inflammation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

The incidence and implications of aldosterone breakthrough

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Prognostic significance of arterial stiffness measurements in end-stage renal disease patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Statistics notes: Analysing controlled trials with baseline and follow up measurements

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Impact of aortic stiffness on survival in end-stage renal disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension

21 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Ambulatory arterial stiffness index: determinants and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Pulse-wave morphology and pulse-wave velocity in healthy human volunteers: examination conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Longitudinal observations on circadian blood pressure variation in chronic kidney disease stages 3-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

The association between aortic augmentation index and cardiovascular risk factors in a large unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Ambulatory arterial stiffness index in chronic kidney disease stage 2-5. Reproducibility and relationship with pulse wave parameters and kidney function.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3660355

Differences Between Cardiac and Arterial Fibrosis and Stiffness in Aldosterone-Salt Rats: Effect of Eplerenone

25 November 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0064549

Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease

21 January 2018

1 reference

12 December 2020

Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure

1 reference

12 December 2020

Arterial wave reflections and survival in end-stage renal failure

1 reference

12 December 2020

Plasma aldosterone concentrations in chronic renal disease

1 reference

12 December 2020

Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function

1 reference

12 December 2020

Association of increased arterial wave reflections with decline in renal function in chronic kidney disease stages 3 and 4

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0064549

Identifiers

DOI

1 reference

16 August 2017

0 references

1 reference

16 August 2017

1 reference